Activity and adverse events of actinium-225-PSMA-617 in advanced metastatic castration-resistant prostate cancer after failure of lutetium-177-PSMA - Feuerecker, Benedikt; Tauber, Robert; Knorr, Karina; Heck, Matthias; Beheshti, Ali; Seidl, Christof; Bruchertseifer, Frank; Pickhard, Anja; Gafita, Andrei; Kratochwil, Clemens; Retz, Margitta; Gschwend, Jürgen E.; et al. (European urology, 2021)
Available online 5 December 2020